Bucladesine ( DrugBank: Bucladesine )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
246メチルマロン酸血症1

246. メチルマロン酸血症


臨床試験数 : 23 薬物数 : 31 - (DrugBank : 8) / 標的遺伝子数 : 17 - 標的パスウェイ数 : 23
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-jRCT2041210065
04/09/202104/09/2021A Phase I/II Study of Bucladesine in Patients with Severe Methylmalonic AcidemiaA Phase I/II Multi-Institutional Study of Bucladesine in Patients with Severe Methylmalonic Acidemia - McAMP methylmalonic acidemia;C537358Bucladesine will be administered intravenously over 60 minutes once a week. Starting dose is 0.3mg/kg. Dosage will be incerased to 0.55mg/kg, then 1.65mg/kg with monitoring PK and safety data.Ito TetsuyaNULLRecruiting>= 3month oldNot applicableBoth6Phase 1-2Japan